Re: Anti-Tumour Activity of Two Novel Compounds in Cisplatin-Resistant Testicular Germ Cell Cancer Editorial Comment

被引：0
作者：
Richie, Jerome P.
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 190卷 / 05期
关键词：
D O I：
10.1016/j.juro.2013.07.032
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1767 / 1768
页数：2
相关论文
共 50 条
  • [31] Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure
    Sagawa, Yasukazu
    Fujitoh, Atsuya
    Nishi, Hirotaka
    Ito, Hiroe
    Yudate, Tamaki
    Isaka, Keiichi
    TUMOR BIOLOGY, 2011, 32 (02) : 399 - 408
  • [32] Testicular germ cell cancer despite previous local radiotherapy to the testis - Editorial comment
    Heidenreich, A
    EUROPEAN UROLOGY, 2002, 41 (06) : 649 - 650
  • [33] Glypican 3 (GPC3) expression in a lethal subgroup of refractory cisplatin-resistant testicular germ cell tumor (TGCT).
    Chahoud, Jad
    Zhang, Miao
    Lin, Song-Chang
    Lin, Sue-Hwa
    Tu, Shi-Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [34] Reply: 'Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'
    Omlin, A.
    Pezaro, C. J.
    Zaidi, S.
    Lorente, D.
    Mukherji, D.
    Bianchini, D.
    Ferraldeschi, R.
    Sandhu, S.
    Dearnaley, D.
    Parker, C.
    Van As, N.
    de Bono, J. S.
    Attard, G.
    BRITISH JOURNAL OF CANCER, 2014, 110 (01) : 267 - 268
  • [35] Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer’
    A Omlin
    C J Pezaro
    S Zaidi
    D Lorente
    D Mukherji
    D Bianchini
    R Ferraldeschi
    S Sandhu
    D Dearnaley
    C Parker
    N Van As
    J S de Bono
    G Attard
    British Journal of Cancer, 2014, 110 : 267 - 268
  • [36] Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line
    D C J Spierings
    E G E de Vries
    E Vellenga
    S de Jong
    Cell Death & Differentiation, 2003, 10 : 808 - 822
  • [37] Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line
    Spierings, DCJ
    de Vries, EGE
    Vellenga, E
    de Jong, S
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (07) : 808 - 822
  • [38] How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer? Editorial comment
    Albers, P
    EUROPEAN UROLOGY, 2001, 40 (06) : 684 - 684
  • [39] Re-inducing sensitivity to abiraterone acetate, a novel CYP17 inhibitor with a high level of anti-tumour activity in castration resistant Prostrate cancer
    Oommen, N.
    Attard, G.
    Reid, A.
    Folkerd, L.
    Fong, P.
    Hunt, J.
    Dowsett, M.
    Dearnaley, D.
    Parker, C.
    De-Bono, J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 51 - 51
  • [40] Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer
    Bryant, Jennifer L.
    Gieling, Roben G.
    Meredith, Suzanne L.
    Allen, Tiffany-Jayne
    Walker, Leanne
    Telfer, Brian A.
    Supuran, Claudiu T.
    Williams, Kaye J.
    White, Anne
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (01) : 191 - 201
12345